Aridis Pharmaceuticals, Inc.
Aridis Pharmaceuticals, Inc. (ARDS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARDS · as of Jun 8, 2026
Key Statistics
Explore Aridis Pharmaceuticals, Inc. Data
ards stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
Competitors & Peers
ards competitorsARDS
AFIB
BTAX
EVLO
HSTC
ICCTStock Performance
Full HistoryAbout Aridis Pharmaceuticals, Inc.
Aridis Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapies, specifically employing fully human monoclonal antibodies (m…
what is aridis pharmaceuticals, inc. · ards stock overview · aridis pharmaceuticals, inc. company profile · who is aridis pharmaceuticals, inc. ceo · ards OTC · aridis pharmaceuticals, inc. headquarters · aridis pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Aridis Pharmaceuticals, Inc. (ARDS) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 14, 2018. As of the latest trading session, ARDS stock price is $0.00, with a market capitalization of $8,915. The stock has returned +100.00% over the past 12 months and -86.67% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Aridis Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Aridis Pharmaceuticals, Inc. reported revenue of — and net income of -$30.7M. For detailed data — including Aridis Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aridis Pharmaceuticals, Inc. (ARDS) stock price is $0.00. The stock is traded on OTC under the ticker symbol ARDS. The 52-week range is $0.00 – $0.05.